US2008081062A1PendingUtilityA1
Medical apparatus and method for producing same
Est. expiryOct 3, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61L 29/06A61P 31/00A61L 29/16A61L 2300/406A61P 31/04
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medical device that includes at least one antibiotic in a macromolecular substance that swells upon contact with a solvent. Also, a method for preparing an antibiotic-containing medical device that involves contacting a medical device having at least a portion of the surface formed from a swellable macromolecular substance, with a solvent that swells the macromolecular substance, contacting the swollen macromolecular substance with at least one antibiotic, and removing the solvent from the swollen macromolecular substance.
Claims
exact text as granted — not AI-modified1 . A method for preparing an antibiotic-containing medical device comprising:
(a) providing a medical device having at least a portion of the surface formed from a swellable macromolecular substance, (b) contacting the medical device with a solvent that swells the macromolecular substance) (c) contacting the swollen macromolecular substance with at least one antibiotic, and (d) removing the solvent from the swollen macromolecular substrate.
2 . The method of claim 1 wherein the medical device comprises a synthetic resin.
3 . The method of claim 2 wherein the synthetic resin is selected from the group consisting of a polyurethane, a polyamide, and combinations thereof.
4 . The method of claim 1 wherein the solvent comprises an aprotic polar solvent.
5 . The method of claim 4 wherein the aprotic polar solvent is selected from the group consisting of dimethylformamide, dimethyl sulphoxide, dimethylacetamide, 2-butanone, acetone, acetinitrile, N-methylpyrrolidone, and combinations thereof.
6 . The method of claim 1 wherein the antibiotic is a water soluble antibiotic.
7 . The method of claim 6 wherein the water soluble antibiotic is selected from the group consisting of isepamicin sulphate, amikacin sulphate, tobramycin, kitasamycin tartrate, and combinations thereof.
8 . The method of claim 1 , wherein the antibiotic is retained within the macromolecular substance.
9 . The method of claim 1 , wherein at least a portion of the macromolecular substance comprises a meshwork structure, and the antibiotic is retained in said meshwork structure.
10 . The method of claim 1 wherein the solvent is removed from the swollen macromolecular substance by a method selected from the group consisting of drying, washing, and combinations thereof.
11 . A medical device produced by the method of claim 1 .
12 . A medical device comprising a synthetic resin comprising a macromolecular substance that swells upon contact with a solvent, and that has at least one antibiotic in the macromolecular substance.
13 . The medical device of claim 12 wherein the synthetic resin is selected from the group consisting of a polyurethane, a polyamide, and combinations thereof.
14 . The medical device of claim 12 wherein the antibiotic is a water soluble antibiotic.
15 . The medical device of claim 14 wherein the water soluble antibiotic is selected from the group consisting of isepamicin sulphate, amikacin sulphate, tobramycin, kitasamycin tartrate, and combinations thereof.
16 . The medical device of claim 12 wherein the solvent is an aprotic polar solvent.
17 . The medical device of claim 12 wherein the medical device is selected from the group consisting of a catheter and a tube.
18 . The medical device of claim 12 wherein at least a portion of the macromolecular substance comprises a meshwork structure and the antibiotic is retained in said meshwork structure.
19 . The medical device of claim 18 wherein the antibiotic is a water soluble antibiotic.
20 . The medical device of claim 18 wherein the solvent is an aprotic polar solvent.
21 . The medical device of claim 18 wherein the medical device is selected from the group consisting of a catheter and a tube.Join the waitlist — get patent alerts
Track US2008081062A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.